A. Maksimenko

发表

Optimisation of dendrimer‐mediated gene transfer by anionic oligomers

M. Gottikh, J. Majoral, C. Malvy, 2003, The journal of gene medicine.

Self-assembly of polyisoprenoyl gemcitabine conjugates: influence of supramolecular organization on their biological activity.

P. Couvreur, F. Meneau, A. Maksimenko, 2014, Langmuir : the ACS journal of surfaces and colloids.

Combined antitumoral therapy with nanoassemblies of bolaform polyisoprenoyl paclitaxel/gemcitabine prodrugs

P. Couvreur, A. Maksimenko, J. Mougin, 2014 .

Nanoparticles with in vivo anticancer activity from polymer prodrug amphiphiles prepared by living radical polymerization.

P. Couvreur, A. Maksimenko, J. Nicolas, 2013, Angewandte Chemie.

Uncoupling of the base excision and nucleotide incision repair pathways reveals their respective biological roles.

P. Tauc, J. Brochon, E. Deprez, 2006, Proceedings of the National Academy of Sciences of the United States of America.

Targeting of single-stranded DNA and RNA containing adjacent pyrimidine and purine tracts by triple helix formation with circular and clamp oligonucleotides.

M. Gottikh, C. Malvy, A. Maksimenko, 2000, European journal of biochemistry.

Significant Tumor Growth Inhibition from Naturally Occurring Lipid-Containing Polymer Prodrug Nanoparticles Obtained by the Drug-Initiated Method

P. Couvreur, A. Maksimenko, J. Nicolas, 2014 .

Gemcitabine-based therapy for pancreatic cancer using the squalenoyl nucleoside monophosphate nanoassemblies.

P. Couvreur, A. Maksimenko, J. Mougin, 2015, International journal of pharmaceutics.

Efficient “green” encapsulation of a highly hydrophilic anticancer drug in metal–organic framework nanoparticles

P. Couvreur, A. Maksimenko, S. Monti, 2015, Journal of drug targeting.

Lipid-Conjugation of Endogenous Neuropeptides: Improved Biotherapy against Human Pancreatic Cancer

P. Couvreur, A. Maksimenko, S. Mura, 2015, Advanced healthcare materials.

Synthesis and Hybridization Properties of Oligonucleotide Analogues Containing Ornithine Backbone Modified with Nucleoalanines

M. Gottikh, C. Malvy, A. Maksimenko, 2003 .

Use of oligonucleotides to enhance transfection of plasmids into cells, METHOD AND transfection kit

C. Malvy, A. Maksimenko, M. Gottikh, 2001 .

Therapeutic Modalities of Squalenoyl Nanocomposites in Colon Cancer: An Ongoing Search for Improved Efficacy

P. Couvreur, A. Maksimenko, J. Mougin, 2014, ACS nano.

The Drug-Initiated Method: A Convenient Approach for the Synthesis of Efficient Polymer Prodrug Nanoparticles.

P. Couvreur, A. Maksimenko, J. Nicolas, 2015 .

Physico-chemical and biological properties of antisense phosphodiester oligonucleotides with various secondary structures.

M. Gottikh, C. Malvy, A. Maksimenko, 1999, Nucleosides & nucleotides.

Improving the Antitumor Activity of Squalenoyl‐Paclitaxel Conjugate Nanoassemblies by Manipulating the Linker between Paclitaxel and Squalene

P. Couvreur, S. Wack, A. Maksimenko, 2013, Advanced healthcare materials.

Antisense oligonucleotides containing a sequence stabilized by a secondary structure and pharmaceutical compositions containing them.

C. Malvy, A. Maksimenko, M. Gottikh, 1999 .

Multifunctional squalene-based prodrug nanoparticles for targeted cancer therapy.

P. Couvreur, A. Maksimenko, J. Nicolas, 2014, Chemical communications.

Real-time detection and efficacy of antisense oligonucleotides delivered by PAMAM dendrimers in living cells

C. Malvy, A. Maksimenko, J. Bertrand, 2005 .

Polyisoprenoyl gemcitabine conjugates self assemble as nanoparticles, useful for cancer therapy.

P. Couvreur, A. Maksimenko, E. Lepeltier, 2013, Cancer letters.

Polymer prodrug nanoparticles based on naturally occurring isoprenoid for anticancer therapy.

P. Couvreur, C. Vauthier, A. Maksimenko, 2013, Biomacromolecules.

Effects of silencing the RET/PTC1 oncogene in papillary thyroid carcinoma by siRNA-squalene nanoparticles with and without fusogenic companion GALA-cholesterol.

P. Couvreur, H. Harashima, A. Maksimenko, 2014, Thyroid : official journal of the American Thyroid Association.

A molecular beacon assay for measuring base excision repair activities.

A. Maksimenko, A. Ishchenko, M. Saparbaev, 2004, Biochemical and biophysical research communications.

Versatile and efficient targeting using a single nanoparticulate platform: application to cancer and Alzheimer's disease.

Cristina Airoldi, Patrick Couvreur, Simona Mura, 2012, ACS nano.

A unique squalenoylated and nonpegylated doxorubicin nanomedicine with systemic long-circulating properties and anticancer activity

P. Couvreur, F. Dosio, L. Cattel, 2014, Proceedings of the National Academy of Sciences.

Novel isoprenoyl nanoassembled prodrug for paclitaxel delivery.

Julie Mougin, Patrick Couvreur, Simona Mura, 2013, Bioconjugate chemistry.

Influence of DNA Aptamer Structure on the Specificity of Binding to Taq DNA Polymerase

O. Voronina, A. Maksimenko, V. Lunin, 2003, Biochemistry (Moscow).

Efficacy of siRNA Nanocapsules Targeted Against the EWS–Fli1 Oncogene in Ewing Sarcoma

P. Couvreur, A. Tamaddon, C. Malvy, 2006, Pharmaceutical Research.

Hijacking of the Human Alkyl-N-purine-DNA Glycosylase by 3,N4-Ethenocytosine, a Lipid Peroxidation-induced DNA Adduct*[boxs]

Laurent Gros, Jacques Laval, L. Gros, 2004, Journal of Biological Chemistry.

Oncogene-targeted antisense oligonucleotides for the treatment of Ewing sarcoma

C. Malvy, A. Maksimenko, 2005, Expert opinion on therapeutic targets.

Intravenous delivery of anti-RhoA small interfering RNA loaded in nanoparticles of chitosan in mice: safety and efficacy in xenografted aggressive breast cancer.

P. Opolon, J. Soria, C. Soria, 2006, Human gene therapy.

Comparison of antisense oligonucleotides and siRNAs in cell culture and in vivo.

P. Opolon, A. Vekris, C. Malvy, 2002, Biochemical and biophysical research communications.

Intravenous delivery of anti-RhoA siRNA loaded in nanoparticles of chitosan in mice: safety and efficacy in xenografted breast cancer.

P. Opolon, Hong Li, J. Soria, 2006 .

Characterisation of new substrate specificities of Escherichia coli and Saccharomyces cerevisiae AP endonucleases.

A. Maksimenko, A. Ishchenko, M. Saparbaev, 2003, Nucleic acids research.

Therapeutic Potentialities of EWS‐Fli‐1 mRNA‐Targeted Vectorized Antisense Oligonucleotides

P. Couvreur, C. Malvy, J. Bertrand, 2003, Annals of the New York Academy of Sciences.

Efficacy of dendrimer‐mediated angiostatin and TIMP‐2 gene delivery on inhibition of tumor growth and angiogenesis: In vitro and in vivo studies

Manouchehr Mirshahi, P. Opolon, Hong Li, 2003, International journal of cancer.

Antitumor vectorized oligonucleotides in a model of ewing sarcoma: unexpected role of nanoparticles.

C. Malvy, J. Bertrand, A. Maksimenko, 2009, Oligonucleotides.

Investigation of squalene-doxorubicin distribution and interactions within single cancer cell using Raman microspectroscopy.

P. Couvreur, F. Dosio, B. Stella, 2021, Nanomedicine : nanotechnology, biology, and medicine.

Structural comparison of AP endonucleases from the exonuclease III family reveals new amino acid residues in human AP endonuclease 1 that are involved in incision of damaged DNA.

S. Moréra, A. Maksimenko, A. Vigouroux, 2016, Biochimie.

In Vivo Potentialities of EWS‐Fli‐1 Targeted Antisense Oligonucleotides‐Nanospheres Complexes

P. Couvreur, C. Malvy, J. Bertrand, 2005, Annals of the New York Academy of Sciences.

Versatile and efficient targeting using a single nanoparticulate platform: application to cancer and Alzheimer's disease.

M. Masserini, W. Scheper, M. Gobbi, 2012, ACS nano.